NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

Australia flag Australia · Delayed Price · Currency is AUD
0.1400
+0.0050 (3.70%)
Jan 30, 2026, 4:10 PM AEST
268.42%
Market Cap44.90M
Revenue (ttm)n/a
Net Income-1.85M
EPS-0.01
Shares Out332.58M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume99,150
Average Volume797,041
Open0.1400
Previous Close0.1350
Day's Range0.1350 - 0.1500
52-Week Range0.0340 - 0.2600
Beta1.15
RSI50.86
Earnings DateFeb 25, 2026

About ASX:NSB

NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol NSB
Full Company Profile

Financial Performance

Financial Statements